414 results on '"Schlimok G"'
Search Results
2. Allogeneic stem cell transplantation for acute myeloid leukemia with normal cytogenetics (CN-AML): outcome, risk factors and role of molecular subgroups in 1006 patients - a report from the Acute Leukemia Working Party of EBMT [Abstract]
3. Prinzipien der Immuntherapie
4. Humorale Immuntherapie
5. Zwei Jahre Tumor-Fatigue-Sprechstunde der Bayerischen Krebsgesellschaft e. V.: Was wurde bisher erreicht und wohin geht die Reise?
6. Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer
7. GM-CSF Stimulation of Immune Response in Minimal Residual Cancer
8. RT-PCR for the Diagnosis of Acute Myeloblastic Leukemia with Inv(16) and Detection of Minimal Residual Disease
9. RT-PCR for the Detection of Minimal Residual Disease in Acute Myeloblastic Leukemia with t(8;21) and t(15;17)
10. Long-term Follow Up of a Prospective Multicenter Trial with a High-Dose Cytosine Arabinoside and Daunorubicin Postremission Therapy in Adults with De Novo Acute Myeloid Leukemia
11. Immuntherapie
12. Randomized comparison of pegfilgrastim day 4 versus day 2 for the prevention of chemotherapy-induced leukocytopenia
13. Thoraxchirurgie
14. Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment
15. Prognoserelevanz disseminierter Tumorzellen im Knochenmark: Prospective Studie an 1045 Mammakarzinom — Patientinnen im Stadium I – III
16. Role of Mitoxantrone, High-Dose Cytosine Arabinoside, and Recombinant Human GM-CSF in Aggressive Non-Hodgkin’s Lymphoma
17. Acute Myeloid Leukemia: An Update of Treatment Results with High-Dose Ara-C Consolidation Therapy
18. Monoklonale Antikörper in der Therapie gastrointestinaler Tumoren
19. Micrometastasis of Epithelial Tumors: Signum Mortis for the Patient or the Achilles’ Heel of Cancer?
20. Mitoxantrone, Cytosine Arabinoside, and VP-16 in 36 Patients with Relapsed and Refractory Acute Myeloid Leukemia
21. Consolidation Therapy with High-Dose Cytosine Arabinoside: Experiences of a Prospective Study in Acute Myeloid Leukemia
22. Ponatinib given for advanced leukemia relapse after allo-SCT
23. Micrometastatic Cancer Cells in Bone Marrow: In vitro Detection with Anti-Cytokeratin and in vivo Labeling with Anti-17-1A Monoclonal Antibodies
24. Early allo-SCT for AML with a complex aberrant karyotype—results from a prospective pilot study
25. SPLENOGENIC BONE MARROW SUPPRESSION - DOES IT EXIST? PRESENTATION OF TWO CASES: PH-AB085
26. ALLOGENEIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA WITH NORMAL CYTOGENETICS (CN-AML): OUTCOME, RISK FACTORS AND ROLE OF MOLECULAR SUBGROUPS IN 1006 PATIENTS - A REPORT FROM THE ACUTE LEUKEMIA WORKING PARTY OF EBMT: PH-O127
27. Drohende Cumarinnekrose bei einer 24-jährigen Patientin mit stattgehabter Beinvenenthrombose
28. 65-jährige Patientin mit Thrombopenie und Hyperfibrinolyse bei Mammakarzinom
29. Correction:High-risk additional chromosomal abnormalities at low blast counts herald death by CML (Leukemia, (2020), 34, 8, (2074-2086), 10.1038/s41375-020-0826-9)
30. Risk-adapted induction and consolidation therapy in adults with de novo AML aged ≤ 60 years: results of a prospective multicenter trial
31. A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma
32. Entwicklung und Einsatz antiepithelialer Antikörper bei soliden Tumoren
33. Percutaneous core-needle biopsy of enlarged lymph nodes in the diagnosis and subclassification of malignant lymphomas
34. Rezidivierende Hämoptysen 65-jähriger nierentransplantierter Patient mit beidseitigen Thoraxwandtumoren: 65-jähriger nierentransplantierter Patient mit beidseitigen Thoraxwandtumoren
35. 30jähriger Patient mit unklaren stenokardieformen Schmerzen und nachfolgendem kardiogenem Schock
36. Association between structural and numerical chromosomal aberrations in acute myeloblastic leukemia: a study by RT-PCR and FISH in 447 patients with de-novo AML
37. Minimal residual disease in breast cancer: detection and genomic characterization of disseminated cancer cells
38. Early Metastasis of Human Solid Tumours: Expression of Cell Adhesion Molecules
39. Evolution of blast crisis (BC) in chronic myeloid leukemia (CML) in the imatinib-era: A rare but early event; need for rapid detection. Results of the German CML Study IV.: V281
40. Outcome and Risk Factor Analysis in 173 Patients with AML and MDS with Poor Risk Cytogenetics Receiving a Uniform Conditioning Regimen for Allogeneic Stem Cell Transplantation (SCT): V546
41. Allogeneic hematopoietic stem cell transplantation (HSCT) for chronic myeloid leukemia (CML) in the imatinib era: Evaluation of its impact within a subgroup of the German CML Study IV: V56
42. Komplikationen der Chemotherapie
43. Tumor cell contamination of peripheral blood stem cell transplants and bone marrow in high-risk breast cancer patients
44. Current management of vaccination and antibiotic prophylaxis for splenectomy. Part I: Adults: Teil I: Erwachsene
45. Techniken zur Erkennung minimal residueller Erkrankung: Zytologie
46. "Knochenmarksmikrometastasen" epithelialer Tumoren: Nachweis und klinische Bedeutung
47. Der Stellenwert neuer Therapiekonzepte und hämatopoetischer Wachstumsfaktoren bei der Behandlung urologischer Tumoren
48. High-dose cytosine arabinoside and daunorubicin postremission therapy in adults with de novo acute myeloid leukemia: Long-term follow-up of a prospective multicenter trial
49. Rituximab consolidation after high-dose chemotherapy and autologous blood stem cell transplantation in follicular and mantle cell lymphoma: a prospective, multicenter phase II study
50. Myeloid blast crisis evolving during imatinib treatment of an FIP1L1-PDGFR alpha-positive chronic myeloproliferative disease with prominent eosinophilia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.